Vector Models and Indexing for Bioequivalence R&D Document

Data Characteristics in this Category

Bioequivalence study documents originate from internal pharmaceutical company sources. These include clinical trial reports, pharmacokinetic data, statistical analysis reports, and submission dossiers. Document updates depend on the drug development stage, typically occurring after new drug clinical trials or before generic drug submissions. Document structures are highly standardized, adhering to ICH guidelines and regulatory requirements from various national drug agencies, such as the CTD (Common Technical Document) format. Content includes extensive tabular data (e.g., plasma concentration-time curve data, pharmacokinetic parameter tables), figures (e.g., mean plasma concentration curves, statistical analysis plots), and detailed textual descriptions (e.g., study protocols, subject information, adverse event reports). Fields and units follow strict medical and pharmaceutical norms, such as Cmax (peak concentration, unit ng/mL), Tmax (time to peak concentration, unit h), and AUC0-t (area under the plasma concentration-time curve, unit ng·h/mL). This ensures data consistency and comparability.

Constraints on Vector Models and Indexing

Bioequivalence document characteristics impose specific constraints on vector models and indexing. First, the highly structured and standardized nature of documents requires vector models to semantically differentiate between field meanings. For example, Cmax values and Tmax values have entirely different biological meanings and should not be confused, even if numerically similar. Second, documents contain numerous tables and figures. Traditional text segmentation methods may not effectively capture relationships within tabular data. This necessitates more refined preprocessing steps, such as converting tables to structured text or extracting text via image recognition. Third, the strictness of fields and units requires retaining the semantic information of these specialized terms during vectorization. This prevents information loss due to the model's insufficient understanding of professional vocabulary. Finally, the rigor of bioequivalence studies demands high precision and recall for retrieval results. Incorrect or irrelevant retrieval results can lead to significant decision biases. Therefore, optimizing indexing strategies is necessary to improve retrieval quality.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`Chunk size` (Chunk Length)	`500–700 characters` (characters)	Balances common paragraph lengths in bioequivalence reports with semantic completeness. Avoids cutting important arguments or table descriptions.
`Chunk overlap` (Chunk Overlap)	`100–150 characters` (characters)	Ensures contextual continuity between paragraphs, especially when interpreting pharmacokinetic parameters or statistical analysis results.
`Embedding Model`	`text-embedding-v3` or higher	Improves understanding of specialized medical and pharmaceutical terminology and complex sentence structures, enhancing vectorization quality.
`Recall count` (Recall Count)	`Top 10–15 entries` (top 10–15 items)	Balances retrieval efficiency with the need for comprehensive information in bioequivalence studies, ensuring no critical data points are missed.
`Similarity threshold` (Similarity Threshold)	Calibrate based on actual measurements	Requires adjustment based on actual data and business needs. A range of `0.7–0.85` is typically recommended to filter out low-relevance results.
`Rerank result count` (Rerank Return Count)	`Top 5–8 entries` (top 5–8 items)	Reduces secondary processing burden while maintaining accuracy, focusing on the most relevant bioequivalence data.

Common Pitfalls

An "No available channels" error after configuring an API Key usually indicates that group permissions are not correctly assigned to the corresponding model service, preventing FastGPT from calling external Embedding models.
Slow retrieval speed in knowledge base Q&A might be due to not enabling "Retrieve after reranking," or a Chunk size (Chunk Length) set too large, leading to high dimensionality for individual vectors and impacting retrieval efficiency.
Retrieval results containing a large amount of irrelevant or duplicate information often stem from a Similarity threshold (Similarity Threshold) set too low, failing to effectively filter out low-relevance documents, or from inadequate document preprocessing to remove redundant content.

How to Verify Configuration

Execute a series of queries containing specialized bioequivalence terms and parameters. Check if the retrieval results include the expected key information and assess its relevance.
Use FastGPT's backend debugging tools to observe the recalled document chunks. Confirm that Chunk size (Chunk Length) and Chunk overlap (Chunk Overlap) settings preserve complete logical units, such as full pharmacokinetic parameter table entries.
Compare the retrieval effectiveness of different Embedding Models when processing bioequivalence study reports, particularly their ability to understand and match specialized medical vocabulary. Evaluate this using a small test set.
During actual Q&A, monitor user feedback on retrieval result quality and response time. Adjust Similarity threshold (Similarity Threshold) and Recall count (Recall Count) as needed to achieve an acceptable balance for business requirements.

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.